# Safety and Tolerability Study of ZEP-3 Cream (0.1% and 1.0%), Administered Topically In Healthy Volunteers

> **NCT01863160** · PHASE1 · COMPLETED · sponsor: **Shulov Innovate for Science Ltd. 2012** · enrollment: 22 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 0.1% ZEP-3 cream
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01863160
- **Lead sponsor:** Shulov Innovate for Science Ltd. 2012
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-01
- **Final completion:** 2014-02
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2014-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01863160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01863160, "Safety and Tolerability Study of ZEP-3 Cream (0.1% and 1.0%), Administered Topically In Healthy Volunteers". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01863160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*